These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12866349)

  • 1. Clozapine-induced aplastic anemia in a patient with Parkinson's disease.
    Ziegenbein M; Steinbrecher A; Garlipp P
    Can J Psychiatry; 2003 Jun; 48(5):352. PubMed ID: 12866349
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple re-challenges for clozapine neutropenia in Parkinson's disease.
    Komaragiri A; Friedman JH
    Parkinsonism Relat Disord; 2016 Feb; 23():114-5. PubMed ID: 26717858
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
    Wagner ML; Defilippi JL; Menza MA; Sage JI
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurochemical mechanism of rebound psychosis in Parkinson's disease.
    Papapetropoulos S; Mash DC
    Mov Disord; 2005 Apr; 20(4):515. PubMed ID: 15747367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
    Diraoui S; van Melick EJ; Jansen PA
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of psychotic complications of Parkinson disease with clozapine].
    Ozsancak C; Auzou P; Ronzière T; Hannequin D; Augustin P
    Presse Med; 1997 Nov; 26(33):1599-602. PubMed ID: 9452762
    [No Abstract]   [Full Text] [Related]  

  • 7. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine therapeutic plunge in patient with Parkinson's disease.
    Greene P
    Lancet; 1995 May; 345(8958):1172-3. PubMed ID: 7723559
    [No Abstract]   [Full Text] [Related]  

  • 10. Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine.
    Onofrj M; Thomas A; Bonanni L; Iacono D; Gambi F
    Neurol Sci; 2000 Aug; 21(4):209-15. PubMed ID: 11214659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroencephalographic findings with low-dose clozapine treatment in psychotic Parkinsonian patients.
    Neufeld MY; Rabey JM; Orlov E; Korczyn AD
    Clin Neuropharmacol; 1996 Feb; 19(1):81-6. PubMed ID: 8867521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in Parkinson's disease: case studies.
    Salter BC; Anderson KE; Weiner WJ
    Neurol Clin; 2006 May; 24(2):363-9. PubMed ID: 16684637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding other antipsychotics to clozapine.
    Cooke C; de Leon J
    J Clin Psychiatry; 1999 Oct; 60(10):710. PubMed ID: 10549694
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.
    Broadstock M; Ballard C; Corbett A
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine is beneficial for psychosis in Parkinson's disease.
    Kahn N; Freeman A; Juncos JL; Manning D; Watts RL
    Neurology; 1991 Oct; 41(10):1699-700. PubMed ID: 1922830
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease.
    Pinter MM; Helscher RJ
    J Neural Transm Park Dis Dement Sect; 1993; 5(2):135-46. PubMed ID: 8333909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy Body dementia.
    Sadek J; Rockwood K
    Am J Geriatr Psychiatry; 2003; 11(1):112-3. PubMed ID: 12527549
    [No Abstract]   [Full Text] [Related]  

  • 20. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease.
    Divac N; Stojanović R; Savić Vujović K; Medić B; Damjanović A; Prostran M
    Behav Neurol; 2016; 2016():4938154. PubMed ID: 27504054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.